PMX53 [Ligand Id: 579] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL41547
  • C5a1 receptor/C5a anaphylatoxin chemotactic receptor in Human [ChEMBL: CHEMBL2373] [GtoPdb: 32] [UniProtKB: P21730]
There should be some charts here, you may need to enable JavaScript!
  • MC4 receptor/Melanocortin receptor 4 in Human [ChEMBL: CHEMBL259] [GtoPdb: 285] [UniProtKB: P32245]
There should be some charts here, you may need to enable JavaScript!
  • NK2 receptor/Neurokinin 2 receptor in Human [ChEMBL: CHEMBL2327] [GtoPdb: 361] [UniProtKB: P21452]
There should be some charts here, you may need to enable JavaScript!
  • NOP receptor/Nociceptin receptor in Human [ChEMBL: CHEMBL2014] [GtoPdb: 320] [UniProtKB: P41146]
There should be some charts here, you may need to enable JavaScript!
  • V1A receptor/Vasopressin V1a receptor in Human [ChEMBL: CHEMBL1889] [GtoPdb: 366] [UniProtKB: P37288]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
C5a1 receptor/C5a anaphylatoxin chemotactic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2373] [GtoPdb: 32] [UniProtKB: P21730]
ChEMBL Antagonist activity against the C5a receptor F 6.52 pIC50 300 nM IC50 J Med Chem (2002) 45: 1543-1558 [PMID:11931608]
ChEMBL Inhibition of C5a binding to human C5aR expressed in HEK293 cells B 6.98 pIC50 104 nM IC50 Bioorg Med Chem Lett (2006) 16: 5088-5092 [PMID:16876401]
ChEMBL Antagonist activity at human C5aR expressed in human PMN cells assessed as inhibition of glucosaminidase release F 7.51 pIC50 31 nM IC50 Bioorg Med Chem Lett (2006) 16: 5088-5092 [PMID:16876401]
ChEMBL Antagonist activity at C5aR1 in human PMN F 7.52 pIC50 30 nM IC50 J Med Chem (2018) 61: 3253-3276 [PMID:28977749]
ChEMBL Antagonist activity at human C5aR in CD88 transfected RBL cells assessed as inhibition of C5a-induced glucosaminidase release F 7.54 pIC50 29 nM IC50 Bioorg Med Chem Lett (2006) 16: 5088-5092 [PMID:16876401]
ChEMBL Antagonist activity at C5aR1 in HMDM F 7.7 pIC50 20 nM IC50 J Med Chem (2018) 61: 3253-3276 [PMID:28977749]
GtoPdb - - 7.7 pIC50 21 nM IC50 Inflammation (2001) 25: 171-7 [PMID:11403208];
Mol Pharmacol (2004) 65: 868-79 [PMID:15044616];
BMC Biophys (2014) 7: 5 [PMID:25170421];
J Pharmacol Exp Ther (2014) 351: 344-51 [PMID:25150279]
ChEMBL Displacement of [125I-C5a] from C5a receptor in human PBMC by scintillation counting B 7.8 pIC50 15.85 nM IC50 J Med Chem (2010) 53: 4938-4948 [PMID:20527893]
ChEMBL Displacement of [125I-C5a] from C5a receptor in human PBMC by scintillation counting B 7.82 pIC50 15 nM IC50 J Med Chem (2010) 53: 4938-4948 [PMID:20527893]
MC4 receptor/Melanocortin receptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL259] [GtoPdb: 285] [UniProtKB: P32245]
ChEMBL Binding affinity to MC4 receptor B 6.4 pIC50 400 nM IC50 Bioorg Med Chem Lett (2006) 16: 5088-5092 [PMID:16876401]
NK2 receptor/Neurokinin 2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2327] [GtoPdb: 361] [UniProtKB: P21452]
ChEMBL Binding affinity to NK2 receptor B 7.06 pIC50 87 nM IC50 Bioorg Med Chem Lett (2006) 16: 5088-5092 [PMID:16876401]
NOP receptor/Nociceptin receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2014] [GtoPdb: 320] [UniProtKB: P41146]
ChEMBL Binding affinity to ORL1 receptor B 5.66 pIC50 2200 nM IC50 Bioorg Med Chem Lett (2006) 16: 5088-5092 [PMID:16876401]
V1A receptor/Vasopressin V1a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1889] [GtoPdb: 366] [UniProtKB: P37288]
ChEMBL Binding affinity to V1a receptor B 6.13 pIC50 740 nM IC50 Bioorg Med Chem Lett (2006) 16: 5088-5092 [PMID:16876401]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]